Abcur AB is the Nordic division of ADVANZ PHARMA, an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, sold in over 90 countries.

We focus on the development, registration and marketing of a wide range of niche prescription and non-prescription products within the Nordic markets for a number of vital therapeutic indications including addiction, intensive care, pain management, ophthalmology, endocrinology and anaesthesia. View Our Products page for more details.

Our products are manufactured by certified European producers and are made according to European law and in agreement with GMP (Good Manufacturing Practice), as well as in accordance with European environmental requirements.

Research and Development

We strive to make necessary pharmaceuticals available and to improve the available treatment alternatives. Our goal with research and development is to offer high quality pharmaceutical products based on needs of patients, doctors and nurses. This is achieved by a close cooperation with clinical specialists all over the Nordic region.

We base our research and development on well-known pharmaceutical substances to minimise the risks involved with new active substances, instead focusing on improving existing treatments.

Our Vision

Ensuring patients can lead better lives through continued access to high-quality, off-patent medicines by:

• Extending the life of and reviving older brands that originator manufacturers choose to divest from
• Bringing innovation to existing medicines through novel strengths, forms and technologies, providing optimised treatment and convenience
• Reliably providing critical medicines safely and effectively
• All to the highest possible quality standard

Our Values

Global Teams
We work together, combining the intellectual power of our global, multicultural workforce to find ways to improve the lives of patients.

Entrepreneurial
We don’t sit back. We constantly strive to create new opportunities that deliver value by proactively finding opportunities to address complex technical challenges that threaten the supply of our medicines and innovating to bring new products to market that better meet the needs of patients.

Decision Making
We empower our people to use good judgement to make the right choices, enabling individuals to grow within the organisation.

Openness
We believe in open and transparent relationships both internally and externally. We aim to be accessible to our partners, customers and patients and strive to deliver the best possible service.

Integrity
We insist on the highest ethical behaviour in all aspects of our work. We operate in a highly complex and competitive environment, however also aim to do what’s right for the healthcare systems and patients we serve.

Products

Abcur AB was established in 2006 with focus on the development, registration and marketing of a wide range of niche prescriptions within the Nordic markets’ vital therapeutic indications, including intensive care, pain management, ophthalmology, endocrinology and anaesthesia.

In 2014, ADVANZ PHARMA acquired Abcur AB and Focus Pharmaceuticals Limited integrating the pharmacovigilance systems of the two companies. Abcur AB continues to have the marketing authorization for certain products. The headquarters are located in Helsingborg, Sweden, with sales in Sweden, Denmark, Finland, Iceland, and Norway.

Investor Information

To read about our strategic approach, stock price and investor news, please visit our corporate site at www.advanzpharma.com